KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
75 hedge funds and large institutions have $220M invested in Kindred Biosciences, Inc. in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
75
Holding in Top 10
–
Calls
$156K
Puts
–
Top Buyers
| 1 | +$503K | |
| 2 | +$466K | |
| 3 | +$263K | |
| 4 |
Squarepoint
New York
|
+$228K |
| 5 |
Edgewood Management
Greenwich,
Connecticut
|
+$212K |
Top Sellers
| 1 | -$1.06M | |
| 2 | -$981K | |
| 3 | -$971K | |
| 4 |
Morgan Stanley
New York
|
-$657K |
| 5 |
SIA
Sit Investment Associates
Minneapolis,
Minnesota
|
-$478K |